Literature DB >> 7798644

Human keratinocytes express the three major splice forms of vascular endothelial growth factor.

C Ballaun1, W Weninger, A Uthman, H Weich, E Tschachler.   

Abstract

Vascular endothelial growth factor is a powerful mitogen for endothelial cells, recently reported to be produced by keratinocytes. In the present work, we examined human keratinocytes in primary culture for the splice variants of vascular endothelial growth factor. In situ hybridization revealed that 100% of cultured human keratinocytes expressed mRNA for this cytokine, and analysis by reverse transcriptase-polymerase chain reaction indicated that three species of mRNA were produced. Southern hybridization and size calculations of PCR products revealed mRNA species corresponding to 121, 165, and 189 amino-acid forms of this cytokine. Using a rabbit anti-vascular endothelial growth factor antiserum, we radioimmunoprecipitated two molecular weight forms (approximately 45 and 58 kDa, non-reducing conditions) from keratinocyte culture supernatants. Under reducing conditions, three bands of approximately 15, 20, and 24 kDa appeared, corresponding with the predominant forms of vascular endothelial growth factor described. We propose that secretion of vascular endothelial growth factor by human keratinocytes in vivo sustains angiogenesis during physiologic tissue repair and in pathologic states accompanied by neovascularization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798644     DOI: 10.1111/1523-1747.ep12613450

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

1.  Sprouty2 downregulates angiogenesis during mouse skin wound healing.

Authors:  Mateusz S Wietecha; Lin Chen; Matthew J Ranzer; Kimberly Anderson; Chunyi Ying; Tarun B Patel; Luisa A DiPietro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

2.  Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.

Authors:  J Gille; R A Swerlick; S W Caughman
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

3.  Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.

Authors:  Juha P Laurila; Lilja Laatikainen; Maria D Castellone; Parul Trivedi; Jari Heikkila; Ari Hinkkanen; Peiman Hematti; Mikko O Laukkanen
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

4.  Regulation of the spatial organization of mesenchymal connective tissue: effects of cell-associated versus released isoforms of platelet-derived growth factor.

Authors:  S A Eming; M L Yarmush; G G Krueger; J R Morgan
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

5.  Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.

Authors:  B Berse; J A Hunt; R J Diegel; P Morganelli; K Yeo; F Brown; R A Fava
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

6.  An in vitro examination of an extracellular matrix scaffold for use in wound healing.

Authors:  Denis E Solomon
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

7.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation.

Authors:  Brad A Bryan; Tony E Walshe; Dianne C Mitchell; Josh S Havumaki; Magali Saint-Geniez; Arindel S Maharaj; Angel E Maldonado; Patricia A D'Amore
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

9.  Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.

Authors:  Iiro Eerola; Laurence M Boon; John B Mulliken; Patricia E Burrows; Anne Dompmartin; Shoji Watanabe; Romain Vanwijck; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

Review 10.  The molecular pathology of rosacea.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  J Dermatol Sci       Date:  2009-05-29       Impact factor: 4.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.